Skip to main content

Table 2 Baseline characteristics of the number of MetS

From: Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational study

Variables

The number of the presence of MetS

0 n = 52

1 n = 280

2 n = 459

3 n = 531

4 n = 286

5 n = 45

P value

P < 0.05

Male, n(%)

51 (98.0)

251 (89.6)

384 (83.6)

421 (79.2)

224 (78.3)

38 (82.2)

<0.001

a,b,c,d,e,f,g,h

Age, years

59.3 ± 9.0

59.0 ± 10.6

59.7 ± 10.3

59.1 ± 9.9

57.6 ± 11.1

54.3 ± 10.3

0.005

e,i,k,l,m,n

BMI, Kg/m2

24.8 ± 2.7

25.1 ± 2.8

25.8 ± 2.8

26.5 ± 2.9

28.2 ± 3.7

32.4 ± 2.0

 < 0.001

b,c,d,e,f,g,h.i,j,k,l,m,n,o

HT, n(%)

0 (0)

120 (42.8)

272 (59.2)

388 (73.0)

250 (87.4)

41 (91.1)

 < 0.001

a,b,c,d,e,f,g,h,j,k,l,m,n

T2DM, n(%)

0 (0)

31 (11.0)

136 (29.6)

225 (42.3)

155 (54.1)

23 (51.1)

 < 0.001

a,b,c,d,e,f,g,h,j,k,l,m

Poor CC, n(%)

4 (7.6)

40 (14.2)

89 (19.3)

97 (18.2)

102 (35.6)

23 (51.1)

 < 0.001

d,e,h,k,m,n,o

SBP, mmHg

118.2 ± 8.7

126.6 ± 16.3

127.2 ± 16.0

129.3 ± 16.2

132.3 ± 16.9

129.5 ± 12.8

 < 0.001

a,b,c,d,e,g,h,j,k,m

DBP, mmHg

71.0 ± 7.0

75.7 ± 11.3

75.7 ± 10.4

76.9 ± 11.0

78.4 ± 11.6

79.3 ± 10.4

 < 0.001

a,b,c,d,e,h,i,k,l

HR, bpm

67.3 ± 7.0

71.1 ± 10.5

72.1 ± 10.4

72.3 ± 9.7

73.0 ± 11.4

70.7 ± 8.1

0.005

a,b,c,d,e,h

FBG, mmol/L

5.1 (4.6, 5.4)

5.2 (4.8, 5.4)

5.4 (5.0, 6.6)

6.2 (5.3, 8.0)

6.9 (5.9, 8.5)

7.6 (6.5, 9.6)

 < 0.001

b,c,d,e,f,g,h,i,j,k,l,m,n,o

TG, mmol/L

1.2 (0.9, 1.3)

1.1 (0.8, 1.3)

1.2 (1.0, 1.6)

1.6 (1.2, 2.3)

2.2 (1.8, 2.9)

2.5 (2.1, 3.9)

 < 0.001

b,c,d,e,f,g,h,i,j,k,l,m,n,o

GA, %

13.8 (13.1, 15.4)

14.1 (13.2, 15.9)

14.3 (13.4, 16.2)

14.7 (13.4, 17.4)

15.8 (13.8, 19.1)

15.9 (14.2, 19.0)

<0.001

b,c,d,e,f,g,h,i,k,l,m

TC, mmol/L

3.8 ± 0.8

3.9 ± 1.0

3.8 ± 1.1

3.8 ± 1.1

4.0 ± 1.3

4.2 ± 1.0

0.036

k,l,m,n

LDL-C, mmol/L

2.2 ± 0.8

2.3 ± 0.9

2.3 ± 1.0

2.2 ± 0.9

2.3 ± 1.0

2.3 ± 0.8

0.363

 

HDL-C, mmol/L

1.2 (1.1, 1.3)

1.2 (1.1, 1.3)

1.0 (1.0, 1.2)

0.9 (0.8, 1.0)

0.9 (0.8, 1.0)

0.9 (0.8, 1.0)

 < 0.001

b,c,d,e,f,g,h,i,j,k,l,m,n

LVEF, %

54.4 ± 10.3

56.1 ± 8.1

56.0 ± 7.6

56.7 ± 7.4

56.6 ± 7.9

56.6 ± 7.0

0.419

 
  1. a:0vs1,b:0vs2,c:0vs3,d:0vs4,e:0vs5,f:1vs2,g:1vs3,h:1vs4,i:1vs5,g:2vs3,k:2vs4,l:2vs5,m:3vs4,n:3vs5,o:4vs5
  2. METs Metabolic Syndrome, BMI body mass index, HT Hypertension, T2DM type 2 diabetes mellitus, CC Coronary Collateralization, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, FBG Fasting blood glucose, TG Triglycerides, TC Total cholesterol, LDL-C low-density lipoprotein cholesterol; HDL-C high-density lipoprotein cholesterol, GA Glycated albumin, LVEF ventricular ejection fraction